BIOMAT Database Logo BIOMAT Database Logo

Current status of thrombolytic therapy. 1978

L Cudkowicz, and S Sherry

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

L Cudkowicz, and S Sherry
Thrombolytic therapy: Current status.
November 1975, The New England journal of medicine,
L Cudkowicz, and S Sherry
Current status of thrombolytic therapy.
March 1985, Journal of vascular surgery,
L Cudkowicz, and S Sherry
Current status of thrombolytic therapy.
October 1970, The Johns Hopkins medical journal,
L Cudkowicz, and S Sherry
CURRENT STATUS OF THROMBOLYTIC THERAPY.
September 1964, Geriatrics,
L Cudkowicz, and S Sherry
Thrombolytic therapy: current status (2).
June 1988, The New England journal of medicine,
L Cudkowicz, and S Sherry
Thrombolytic therapy: current status (1).
June 1988, The New England journal of medicine,
L Cudkowicz, and S Sherry
The current status of thrombolytic therapy.
August 1997, Australian and New Zealand journal of medicine,
L Cudkowicz, and S Sherry
Thrombolytic therapy in Europe: current status.
September 1996, European heart journal,
L Cudkowicz, and S Sherry
Current status of thrombolytic therapy in acute myocardial infarction.
January 1991, Texas Heart Institute journal,
L Cudkowicz, and S Sherry
Current status of thrombolytic therapy in acute myocardial infarction.
November 1991, Journal of the Indian Medical Association,
Copied contents to your clipboard!